De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.
- DOI
- 10.1177/13524585261430130
- Published
- 2026-03-19
- Container
- Mult Scler
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13524585261430130,
title = {De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.},
author = {Langer-Gould AM and Smith JB and Nielsen AS and Beaber BE and Brara SM and Amirova S and Su E and Li BH and Z Esfahani N and Torres F and Xu S.},
year = {2026},
journal = {Mult Scler},
doi = {10.1177/13524585261430130},
url = {https://doi.org/10.1177/13524585261430130}
}RIS
TY - JOUR TI - De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy. AU - Langer-Gould AM AU - Smith JB AU - Nielsen AS AU - Beaber BE AU - Brara SM AU - Amirova S AU - Su E AU - Li BH AU - Z Esfahani N AU - Torres F AU - Xu S. PY - 2026 JO - Mult Scler DO - 10.1177/13524585261430130 UR - https://doi.org/10.1177/13524585261430130 ER -
APA
AM, L., JB, S., AS, N., BE, B., SM, B., S, A., E, S., BH, L., N, Z. E., F, T., & S., X. (2026). De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.. Mult Scler. https://doi.org/10.1177/13524585261430130
Source records
- europe-pmc · retrieved 2026-09-26T20:51:05.524Z